Osiris shares jump on higher 4Q revenue report Shares of stem cell...

Osiris said its product revenue increased more than 280 percent to $3.1 million in the fourth quarter of 2012, primarily from sales of Grafix, a wound healing implant designed to treat diabetic foot ulcers and other serious injuries.

http://www.news.net/article/181449/Business/?